$43.48
$0.00 (0.00%)
End-of-day quote: 05/18/2024
NasdaqGS:AMPH
Amphastar Pharmaceuticals Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | NYSE | Outperform | $770.00 | $636.99 | 0.00% | 9 | $693.31B |
| NOVO B | Novo Nordisk A/S | CPSE | Outperform | kr903.30 | kr696.07 | 0.00% | 14 | kr4.01T |
| SUNPHARMA | Sun Pharmaceutical Industries | NSEI | Outperform | Rp1.53k | Rp1.52k | 0.00% | 25 | Rp3.68T |
| TEVA | Teva Pharmaceutical Industries | NYSE | Outperform | $16.29 | $11.59 | 0.00% | 9 | $18.45B |
| ZEAL | Zealand Pharma A/S | CPSE | Buy | kr600.00 | kr357.00 | 0.00% | 2 | kr38.52B |
| HIK | Hikma Pharmaceuticals PLC | LSE | Outperform | £19.78 | £28.11 | 0.00% | 9 | £4.42B |
| HALO | Halozyme Therapeutics | NasdaqGS | Outperform | $44.71 | $47.50 | 0.00% | 3 | $5.58B |
| PBH | Prestige Consumer Healthcare | NYSE | Outperform | $64.65 | $71.50 | 0.00% | 3 | $3.55B |
| BHC | Bausch Health Companies | NYSE | Hold | $6.77 | $9.50 | 0.00% | 5 | $2.55B |
| AMRX | Amneal Pharmaceuticals | NYSE | Outperform | $6.82 | $6.13 | 0.00% | 1 | $2.09B |
| SUPN | Supernus Pharmaceuticals | NasdaqGM | Outperform | $29.10 | $41.00 | 0.00% | 0 | $1.72B |
| ANIP | ANI Pharmaceuticals | NasdaqGM | Buy | $61.43 | $69.75 | 0.00% | 1 | $1.38B |
| XERS | Xeris Biopharma Holdings | NasdaqGS | Buy | $1.98 | $4.60 | 0.00% | 1 | $260.93M |
| EBS | Emergent BioSolutions | NYSE | Outperform | $5.55 | $5.00 | 0.00% | 0 | $229.00M |
| ASRT | Assertio Holdings | NasdaqCM | Buy | $1.07 | $3.50 | 0.00% | 2 | $100.36M |
| OPNT | Opiant Pharmaceuticals | NasdaqGM | - | $20.77 | $21.00 | 0.00% | 0 | $63.99M |
| EGRX | Eagle Pharmaceuticals | NasdaqGM | - | $4.76 | $17.00 | 0.00% | 0 | $61.69M |
| LCI | Lannett Company | OTCPK | - | $0.03 | $4.00 | 0.00% | 1 | $21.85M |
| ENDP.Q | Endo International | OTCPK | - | $0.00 | $1.33 | 0.00% | 0 | $1.18M |
| ACOR | Acorda Therapeutics | NasdaqGS | - | $0.43 | $200.00 | 0.00% | 1 | $0.53M |
| DMK | DMK Pharmaceuticals | NasdaqCM | - | $0.03 | $1.50 | 0.00% | 0 | $0.35M |
